The political shift in Washington DC is rippling through to states and may bring additional challenges to officials trying to navigate the changes. Arizona Attorney General Kris Mayes joins Bloomberg Intelligence analysts Justin Teresi and Holly Froum to discuss a wide range of litigation and policy issues on which her office is leading the states. On the antitrust front, we delve into recent cases against RealPage and landlords, like Camden Property Trust, around alleged use of artificial-intelligence algorithms to fix rent prices, and Mayes’ involvement in blocking the Kroger-Albertson’s merger. We also examine the role of Arizona and other states in litigation against manufacturers of forever chemicals, including 3M, DuPont and Chemours, seeking compensation for cleanup efforts across the state.

See omnystudio.com/listener for privacy information.

Dr. Betsy Southerland, former EPA director of the Office of Science and Technology, joins Bloomberg Intelligence Litigation analyst Holly Froum to talk about the regulatory outlook for alleged cancer-linked PFAS, also known as “forever chemicals,” found in drinking water. Dr. Southerland discusses how and why the Trump EPA may roll back Biden-era rules passed in April that designated two of the most widely studied PFAS as hazardous under EPA Superfund laws and set maximum contaminant levels in drinking water. Dr. Southerland discusses how this could impact the safety of water for years to come and how Trump’s EPA may impact legal challenges to the rules by historic manufacturers like Chemours.

See omnystudio.com/listener for privacy information.

What’s the outlook for policies coming out of Washington in 2025? What are markets potentially missing? Will Trump’s threatened tariffs be imposed? Will Congress be able to pass a bill that extends the 2017 Trump-era tax cuts? Will we have a debt ceiling crisis? How will regulators “de-regulate” in their sectors? On the latest edition of Votes and Verdicts, Veda Partners Cofounder and Director of Economic Policy Research Henrietta Treyz and BTIG Managing Director and Director of Policy Research Isaac Boltansky joined BI analysts Elliott Stein and Nathan Dean to discuss these issues and more.

See omnystudio.com/listener for privacy information.

President Trump’s return to the White House brings with it another major shift in Washington: Republicans take control of the federal agencies, including the Federal Communications Commission. With Trump elevating Republican Brendan Carr to FCC chairman, US broadcasters, telecom providers and internet platforms could see major changes. In this episode of Votes and Verdicts, former FCC Commissioner Michael O’Rielly sits down with Bloomberg Intelligence analyst Matthew Schettenhelm of the BI litigation and policy team to share insights on what may lie ahead for federal TMT regulation over the next four years.

See omnystudio.com/listener for privacy information.

TikTok likely didn’t convince the US Supreme Court to overturn a sale-or-ban law that’s set to take effect on Jan. 19, based on Bloomberg Intelligence’s analysis of the Jan. 10 hearing. In this episode of Votes and Verdicts, Litigation Analysts Matt Schettenhelm and Elliott Stein host a Bloomberg Intelligence Spotlight Webinar shortly after the key US Supreme Court argument. They discuss what’s next at the high court, what the Trump administration can do about it, and what it will mean for TikTok, its competitors, and its hosts.

Find this and other Bloomberg Intelligence podcasts at BI PODCASTS .

See omnystudio.com/listener for privacy information.

President-elect Donald Trump’s effect on bank-capital rules, crypto policy, antitrust scrutiny and drug pricing are among key 2025 catalysts that BI litigation and policy analysts are watching. On this 2025 litigation and policy outlook episode of the Votes and Verdicts podcast, the Bloomberg Intelligence litigation team discusses these and other matters, including: the FTC’s case against units of UnitedHealth, CVS and Cigna and other pharmacy benefit managers; TikTok’s lawsuit challenging the US ban-or-divest law; the CFPB credit-card late-fee rule likely getting struck in court; US Steel and Nippon Steel’s lawsuit against the Biden administration. They also examine an anticipated verdict in the FTC’s lawsuit to block Tempur Sealy’s bid for Mattress Firm; Bayer PCB contamination cases; and artificial intelligence and copyright law.

See omnystudio.com/listener for privacy information.

Abbott and Reckitt’s Mead Johnson face over 1,000 claims that preterm infant formula causes necrotizing enterocolitis (NEC) in infants and have been hit with jury verdicts totaling a half a billion dollars so far. In this Votes and Verdicts podcast, Bloomberg Intelligence litigation analysts Holly Froum and Justin Teresi discuss federal and state litigation, key catalysts in 2025, potential exposure, potential settlement value and more.

See omnystudio.com/listener for privacy information.

A key ruling in TikTok’s lawsuit challenging the US “sale or ban” law, a trial in Arm v. Qualcomm litigation over chip-licensing and oral arguments in a Canadian Pacific bondholder appeal in a $2.4 billion suit over redemption rights are litigation catalysts to watch in December. In this Votes and Verdicts episode, Bloomberg Intelligence senior litigation analyst Elliott Stein gathered colleagues to discuss these and other themes. These include expected verdicts in DOJ v. Google over ad tech, in the FTC’s suit in Oregon against the Kroger-Albertsons merger and in a $750 million PCB contamination trial against Bayer/Monsanto. Also discussed were President Biden’s plan to cover anti-obesity drugs under Medicare and Medicaid, deregulation in the financials sector and why crypto is poised to do well with Trump’s victory.

See omnystudio.com/listener for privacy information.